These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Leishmaniasis: drugs in the clinic, resistance and new developments.
    Author: Ouellette M, Drummelsmith J, Papadopoulou B.
    Journal: Drug Resist Updat; 2004; 7(4-5):257-66. PubMed ID: 15533763.
    Abstract:
    The control of Leishmania infections relies primarily on chemotherapy. The arsenal of drugs available for treating Leishmania infections is limited and includes pentavalent antimonials, pentamidine, amphotericin B, miltefosine, fluconazole and few other drugs at various stages of their development process. In this review, we will discuss the latest results regarding resistance mechanisms to drugs used in the clinic against Leishmania infections.
    [Abstract] [Full Text] [Related] [New Search]